Cancer, Aging, and Comorbidities Webinar Series (Agenda)


Each session will allocate ~ 20 minutes for discussion of opportunities and future directions of the research area(s) and addressing questions from the audience. Meeting recordings will be posted on this page.

January 27, 2023, Friday, 2:00 PM to 3:00 PM, ET

Session I. Keynote Speech

Co-moderators: Diane St. Germain and Weiwei Chen

Keynote Speech: Addressing Comorbidity in Cancer Research:  New Considerations for an Older Dilemma, presented by Supriya Mohile, M.D., M.S., University of Rochester Medical Center

February 1, 2023, Wednesday, 1:00 PM to 2:00 PM, ET

Session II. Comorbidities and Cancer Clinical Trial Design

Co-moderators: Jeff Buchsbaum, Diane St. Germain, and Rich Little

Edith P. Mitchell, M.D., Thomas Jefferson University
Andrea Denicoff, R.N., M.S. National Cancer Institute
Harvey Jay Cohen, M.D., Duke University
Unger, Joseph M, Ph.D., M.S., Fred Hutchinson Cancer Research Center

March 30, 2023, Thursday, 3:00 PM to 4:00 PM, ET

Session III. Impact of Comorbidities on Treatment Tolerability and Patient Outcomes

Co-moderators: Rachel Altshuler and Diane St. Germain

Martine Extermann, M.D., Ph.D., H Lee Moffitt Cancer Center & Research Institute
Marie Flannery, Ph.D., University of Rochester Medical Center
Aarti Asnani, M.D., Harvard Medical School

April 12, 2023, Wednesday, 11:00 AM – 12:00 PM, ET

Session IV. Wearable Devices to Measure Comorbidities and Improve Cancer Treatment

Co-moderators: Mike Espey, Piotr Grodzinski, and Carolina Salvador Morales

Wei Gao, Ph.D., California Institute of Technology
Karen M. Mustian, Ph.D., M.P.H., University of Rochester Medical Center
Andrew Laccetti, M.D., M.S., Memorial Sloan Kettering Cancer Center

May 9, 2023, Tuesday, 2:00 PM – 3:15 PM, ET

Session V. Microbiome as A Comorbidity in Cancer Therapy

Co-moderators: Phil Daschner, Mike Espey, and Pat Prasanna

Ann Klopp, Ph.D., University of Texas MD Anderson Cancer Center
Matthew Redinbo, Ph.D., University of North Carolina at Chapel Hill
Peter Turnbaugh, Ph.D., University of California, San Francisco

June 15, 2023, Thursday, 1:00 PM – 2:00 PM, ET

Session VI. Food as a Drug

Co-moderators: Phil Daschner, Mike Espey, and Pat Prasanna

Lydia Lynch, Ph.D., Harvard Medical School
Nicole Simone, M.D., Thomas Jefferson University

July 14, 2023, Friday, 2:00 PM – 3:00 PM, ET

Session VII. Senescence, Cancer Treatment-Associated Accelerated Aging, and Comorbidities

Co-moderators: Jennifer Guida and Weiwei Chen

James L. Kirkland, M.D., Ph.D., Mayo Clinic
Judi Campisi, Ph.D., Buck Institute for Research on Aging